These changes are meant to limit the use of the shots while experts collect more data on how well they work for healthy people.

New research suggests that outpatients with cancer are more likely than other outpatients to have antimicrobial-resistant bacterial pathogens.

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy.

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy.

Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

Understanding causes of death among men with prostate cancer recurrence after localized treatment is essential for informed decision-making.

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

Order expected to affect specific medications covered under Medicare that are administered in a health care setting.

SGLT2 inhibitors may enable continuation of RAAS inhibitors for hypertension treatment, which is linked with better kidney and cardiovascular outcomes.

Treating lupus nephritis to achieve sustained remission for at least 3 years likely protects kidney function. In patients with active lupus nephritis, at least 3 years of sustained clinical ...